ASP4132

CAS No. 1640294-30-9

ASP4132( —— )

Catalog No. M22042 CAS No. 1640294-30-9

ASP4132 is an orally active AMPK activator (EC50 : 18 nM), has anti-cancer activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 79 Get Quote
5MG 120 Get Quote
10MG 186 Get Quote
25MG 338 Get Quote
50MG 507 Get Quote
100MG 714 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ASP4132
  • Note
    Research use only, not for human use.
  • Brief Description
    ASP4132 is an orally active AMPK activator (EC50 : 18 nM), has anti-cancer activity.
  • Description
    ASP4132 is an orally active AMPK activator (EC50 : 18 nM), has anti-cancer activity.(In Vitro):ASP4132 shows comparable cell growth inhibitory (IC50=0.014 μM) activity against MDA-MB-453 breast cancer cell.ASP4132 shows relatively weak antiproliferative activity against SK-BR-3 (IC50>3 μM).(In Vivo):ASP4132 (0.5-8 mg/kg; PO; once daily; for 21 days) causes the tumor growth inhibition and regression.ASP4132 (1 mg/kg; IV or PO) has a T1/2 of 3.6 hours, a CLtot of 19 mL/min kg, and a Vss of 4.6 L/kg for rats for IV.ASP4132 is stable in human liver microsomes (HLM CLint, vitro=61 mL/min kg).
  • In Vitro
    ASP4132 shows comparable cell growth inhibitory (IC50=0.014 μM) activity against MDA-MB-453 breast cancer cell. ASP4132 shows relatively weak antiproliferative activity against SK-BR-3 (IC50>3 μM).
  • In Vivo
    ASP4132 (0.5-8 mg/kg; PO; once daily; for 21 days) causes the tumor growth inhibition and regression. ASP4132 (1 mg/kg; IV or PO) has a T1/2 of 3.6 hours, a CLtot of 19 mL/min?kg, and a Vss of 4.6 L/kg for rats for IV. ASP4132 is stable in human liver microsomes (HLM CLint, vitro=61 mL/min?kg). Animal Model:Five-week-old male nude mice with MDA-MB-453 Dosage:0.5, 1, 2, 4, 8 mg/kg Administration:PO; once daily; for 21 days Result:The tumor growth inhibition (TGI) rate was 29% at 1 mg/kg, and the tumor regression rate was 26%, 87% and 96% at 2, 4 and 8 mg/kg, respectively. Animal Model:Male SD rats Dosage:1 mg/kg (Pharmacokinetic Analysis) Administration:IV or PO Result:Had a T1/2 of 3.6 hours, a CLtot of 19 mL/min?kg, and a Vss of 4.6 L/kg for rats for IV. Had a Cmax of 72 ng/mL and an AUC24h of 705 ng?h/mL for PO.
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AMPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1640294-30-9
  • Formula Weight
    937.06
  • Molecular Formula
    C46H51F3N6O8S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:230 mg/mL (245.45 mM; Need ultrasonic); Methanol:8.33 mg/mL (8.89 mM; Need ultrasonic)
  • SMILES
    CC1=CC=C(C=C1)S(O)(=O)=O.CC1=CC=C(C=C1)S(O)(=O)=O.COC1=CC=C(CN2CCC(CC2)C2=CC=C3N=C(NC3=C2)C(=O)N2CCN(CC3=CC=C(C=C3)C(F)(F)F)CC2)C=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kazuyuki Kuramoto , Yuki Sawada, Tomohiro Yamada,et al.Novel Indirect AMP-Activated Protein Kinase Activators: Identification of a Second-Generation Clinical Candidate with Improved Physicochemical Properties and Reduced hERG Inhibitory Activity.Chem Pharm Bull (Tokyo). 2020;68(5):452-465.
molnova catalog
related products
  • YLF-466D

    YLF-466D (C24) is a novel AMPK activator that inhibits platelet aggregation.

  • PF-06679142

    PF-06679142 is a novel potent, orally active, α1β1γ1/α2β1γ1-isoform selective AMPK activator with Kd of 14 nM, EC50 of 22 nM for α1β1γ1-AMPK.

  • Tectochrysin

    Tectochrysin leads to apoptotic cell death in NSCLC cells through activation of DR3 and Fas expression via inhibition of STAT3 phosphorylation.